Guidelines for Managing Post-Menopausal Symptoms with Esterified Estrogens/Methyltestosterone

Introduction to Guidelines and Recommendations

• The U.S. Preventive Services Task Force recommends against the use of hormone therapy, including combinations with androgens, for the primary prevention of chronic conditions in postmenopausal women 1
• The American College of Obstetricians and Gynecologists recommends caution in using hormone therapy solely to prevent osteoporosis and suggests that alternative therapies should be considered 4

Safety and Efficacy Considerations

• Current guidelines emphasize that hormone therapy should be used primarily for symptom management rather than prevention of chronic conditions 3
• For women with an intact uterus requiring hormone therapy, guidelines typically recommend estrogen plus progestin rather than estrogen plus androgen combinations 3
• Prescribing esterified estrogens/methyltestosterone for primary prevention of chronic conditions like osteoporosis or cardiovascular disease is not recommended 1, 2
• Failing to consider alternative therapies with potentially better safety profiles for menopausal symptom management should be avoided 3